Search research articles
Contact Us
Filters
Showing results (1-10 of 61) with videos related to
Page
of 7
Sort By:
Cellular and Molecular Neurobiology
|
June 5, 2002
6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease
H Elkon, E Melamed, D Offen
Journal of Neural Transmission. Supplementum
|
December 29, 2000
Apoptosis as a general cell death pathway in neurodegenerative diseases
D Offen, H Elkon, E Melamed
Handbook of Experimental Pharmacology
|
June 8, 2007
Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseases
I Kan, E Melamed, D Offen
Current Drug Targets
|
February 22, 2005
Integral therapeutic potential of bone marrow mesenchymal stem cells
I Kan, E Melamed, D Offen
Neuropharmacology
|
June 19, 2001
Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier
Y Gilgun-Sherki, E Melamed, D Offen
Journal of Neurology
|
September 19, 2000
Levodopa--an exotoxin or a therapeutic drug?
E Melamed, D Offen, A Shirvan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1986
U1, U2, and U6 small nuclear ribonucleoproteins (snRNPs) are associated with large nuclear RNP particles containing transcripts of an amplified gene in vivo
R Sperling, P Spann, D Offen, et al.
Clinical Neuropharmacology
|
April 6, 2001
Catechol-O-methyltransferase decreases levodopa toxicity in vitro
D Offen, H Panet, R Galili-Mosberg, et al.
Journal of Neurochemistry
|
April 12, 2001
Activation of nuclear transcription factor kappa B (NF-kappaB) is essential for dopamine-induced apoptosis in PC12 cells
H Panet, A Barzilai, D Daily, et al.
Molecular Biology Reports
|
January 1, 1990
Identification of nuclear RNP proteins as pre-mRNA splicing factors
G Ast, D Offen, D Goldblatt, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 61) with videos related to
Sort By:
Page
of 7
Cellular and Molecular Neurobiology
|
June 5, 2002
6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease
H Elkon, E Melamed, D Offen
Journal of Neural Transmission. Supplementum
|
December 29, 2000
Apoptosis as a general cell death pathway in neurodegenerative diseases
D Offen, H Elkon, E Melamed
Handbook of Experimental Pharmacology
|
June 8, 2007
Autotransplantation of bone marrow-derived stem cells as a therapy for neurodegenerative diseases
I Kan, E Melamed, D Offen
Current Drug Targets
|
February 22, 2005
Integral therapeutic potential of bone marrow mesenchymal stem cells
I Kan, E Melamed, D Offen
Neuropharmacology
|
June 19, 2001
Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier
Y Gilgun-Sherki, E Melamed, D Offen
Journal of Neurology
|
September 19, 2000
Levodopa--an exotoxin or a therapeutic drug?
E Melamed, D Offen, A Shirvan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 1, 1986
U1, U2, and U6 small nuclear ribonucleoproteins (snRNPs) are associated with large nuclear RNP particles containing transcripts of an amplified gene in vivo
R Sperling, P Spann, D Offen, et al.
Clinical Neuropharmacology
|
April 6, 2001
Catechol-O-methyltransferase decreases levodopa toxicity in vitro
D Offen, H Panet, R Galili-Mosberg, et al.
Journal of Neurochemistry
|
April 12, 2001
Activation of nuclear transcription factor kappa B (NF-kappaB) is essential for dopamine-induced apoptosis in PC12 cells
H Panet, A Barzilai, D Daily, et al.
Molecular Biology Reports
|
January 1, 1990
Identification of nuclear RNP proteins as pre-mRNA splicing factors
G Ast, D Offen, D Goldblatt, et al.
Page
of 7